04:38 Tue 29 Jan 2019
Advanced Oncotherapy - Total Voting Rights and Significant Shareholdings
("
Total Voting Rights and Director and Significant Shareholdings
The Company's issued share capital now consists of 194,566,092 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 194,566,092. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the
Directors' and Significant Shareholdings
Set out below are details of the Directors' beneficial shareholdings and, in so far as the Company has been made aware, shareholdings of certain new Significant shareholders following Admission, being
Shareholder |
Number of Shares |
% of issued share capital |
|
45,000,000 |
23.13% |
DNCA Investments |
12,000,000 |
6.17% |
Barrymore Investments Ltd* |
7,905,721 |
4.06% |
Mr Michael S Bradfield (Non-executive Director) |
7,080,740 |
3.64% |
Dr |
6,594,660 |
3.39% |
|
6,488,789 |
3.34% |
Dr P N Plowman (Non-executive Director) |
3,930,304 |
2.02% |
Dr |
1,926,361 |
0.99% |
Mr |
1,760,467 |
0.90% |
Professor |
783,902 |
0.40% |
Mr |
30,000 |
0.02% |
*
**
Defined terms in this announcement shall have the same meaning as in the announcement of
|
|
Dr. |
Tel: +44 20 3617 8728 |
|
|
|
|
Stockdale Securities (Nomad & Joint Broker) |
|
|
Tel: +44 20 7601 6100 |
|
|
Stifel Nicolaus Europe (Joint Broker) |
|
|
Tel: +44 20 7710 7600 |
|
|
Walbrook PR (Financial PR & IR) |
Tel: +44 20 7933 8780 or avo@walbrookpr.com |
|
Mob: +44 7980 54 1 893 / Mob: +44 7876 741 001 |
About
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE